VYGR

MKT CAP:$229M

Voyager Therapeutics Inc

Market Cap

$229M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.33-$0.70 (-17.37%)

Jun 5, 2026

52W High $5.3352W Low $2.94

Company Details

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the tr...

CEO

—

IPO Date

Nov 11, 2015

Website

www.voyagertherapeutics.com

Key Metrics TTM

Revenue

$36M

-45.5% YoY

Net Income

-$117M

EPS (Diluted)

Free Cash Flow

-$130M

Revenue / Share

$0.61

Gross Margin

97.4%

Operating Margin

-349.2%

Net Margin

-319.6%

FCF Margin

-356.1%

P/S

6.3x

P/E

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

May 7, 2026

$3M-59.9%

FY 2025

Mar 9, 2026

$40M-49.5%

Q4 2025

Mar 9, 2026

$15M+144.3%

Q3 2025

Nov 10, 2025

$13M-45.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee